Published Date : 2025-Apr-07
As the healthcare landscape continues to shift towards more consumer-centric care, the global self-testing market has emerged as a critical segment. Empowering individuals with tools to manage their own health, self-testing kits are pivotal in early diagnosis, chronic disease management, and infectious disease detection (such as COVID-19 and STDs).
The market is predicted to gain revenue of about $26.9 Billion by 2032 is set to record a CAGR of nearly 6.7% over the period from 2024 to 2032.
Based on recent industry reports, here are the top companies leading the self-testing revolution in 2025.
The growth in the self-testing industry is due to increased focus on personalized health care, technological advances in rapid diagnostics, and demand for easy and rapid diagnostics kits. Self-test/kits are applied for the rapid diagnosis of vast ranges of diseases. Moreover, high awareness of the benefits of early diagnosis and regular monitoring have been driving the application of self-testing kits, and augmenting product launches are also expected to positively impact the market for self-testing.
The COVID-19 pandemic has fast-forwarded the need and emphasis on self-testing kits with an aim to increase the rate of diagnosis. Many organizations have implemented various efforts to reduce the risk of serious disease, hospitalizations, or death. For instance, in January 2024, the ASPR and NIH took off the Home Test to Treat program. This is a virtual community health intervention, which has free COVID-19 health services, which include telehealth consultations, home treatments, and at-home rapid tests, in a few selected communities. Such factors further boost the self-testing industry.
Expanding regulatory approvals are promoting market growth through increased confidence in self-testing products. The more the diagnostic tools gain approval from renowned regulatory bodies, such as the WHO and FDA, the more accepted and credible they become. This opens up avenues for consumers and healthcare providers to use accurate and reliable testing options. Regulations beyond safety allow for opening avenues in the aspects of market growth. This is because new self-testing solutions will be developed and available across various healthcare sectors. For instance, in July 2022, Innova received a CE mark for its rapid antigen self-test, which can facilitate the distribution of the product across European markets. This approval is significantly boosting the availability of at-home COVID-19 testing solutions and is making access easier for consumers, where capacity to manage the pandemic will also increase. The CE mark attests that the test shall comply with all necessary requirements on safety, health, and environmental protection laid down in the European Union, thus strengthening confidence in its reliability and effectiveness.
Organizations, as well as other market players, with the development of strong and innovative diagnostics have made tremendous opportunities for the market with additional funding and investments. For example, in January 2022, the Florida Atlantic University (FAU) agreed on the funding of USD 1.3 million for NIH to develop rapid and automated HIV self-test. In April 2022, a start-up company called Cervicheck, based in India, received approval from the CDSCO for the commercialization of its product in India. The product is a diagnostic kit for Human Papillomavirus (HPV).
Overview: A dominant player in diagnostics, Abbott offers a wide array of self-testing devices such as glucose monitors (Freestyle Libre) and COVID-19 rapid antigen tests.
Overview: Known for its diagnostics and bioscience solutions, BD provides self-collection devices and STD home testing kits.
Overview: A global pioneer in diagnostics, Roche offers at-home COVID-19 test kits, glucose monitoring, and women’s health tests.
Overview: Offers innovative at-home diagnostic solutions including pregnancy and ovulation testing kits and point-of-care tests.
Overview:True Diagnostics specializes in point-of-care diagnostics and rapid testing solutions. It gained increased attention during the COVID-19 pandemic due to its EUA-approved rapid antigen tests and continues to develop lateral flow assays and biosensor platforms.
Overview: Innovators in self-testing, best known for the first HIV self-test approved in the UK.
Overview: Focuses on infectious disease diagnostics, including FDA-approved HIV and COVID-19 self-testing kits.
Overview: A digital health platform offering a wide variety of lab-certified home testing kits with telehealth integration.
Overview: Offers affordable and convenient self-test kits including food sensitivity, fertility, and COVID-19 tests.
Overview: Specializes in discreet at-home STD and general health testing kits, shipped directly to consumers.
Region | Market Share (%) | Highlights |
North America | 38% | Strong infrastructure, tech adoption, consumer awareness. |
Europe | 28% | Regulatory support, demand for chronic disease monitoring. |
Asia-Pacific | 22% | Rising healthcare spending, population growth, expanding urbanization. |
Latin America | 7% | Growth fueled by partnerships and rising public-private initiatives. |
MEA | 5% | Gradual development, key focus on HIV and malaria self-testing.
|
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. In North America, where consumer demand is very high, healthcare infrastructure is well-developed, and preventive care emphasizes growing demand, self-testing products are among the largest markets. Products used for self-testing - COVID-19 kits, pregnancy tests, blood glucose monitors, among others - have become household names in the United States, where a consumer's desire for convenience and speed of results is becoming increasingly important on their agendas. This region is also highly aware and trusting of healthcare technologies, supported by regulatory frameworks such as the FDA that guarantees the quality and safety of the product.
The market is also considerable in Europe due to the fact that its demand is reasonably big, especially within Germany, UK, and France. A developing healthcare cost and an aging population, along with the shift in home-based health solutions, will drive this market. Europeans demand affordable and easily accessible health testing. The pandemic of COVID-19 has boosted this demand in health testing.
At present, the highest growth in the market is in the Asia-Pacific region, particularly in China, India, and Japan. The demand for self-testing products comes from rapid urbanization, greater disposable incomes, and an ever-expanding middle class. Besides these, access to healthcare in rural Asia is relatively less, and self-testing devices have solved the need for consumers as well. The booming health-conscious younger generations further drive the market.
Latin America and Middle East & Africa are seeing the emergence of the self-testing market, as affordable health care solutions and e-commerce platforms expand. Demand for self-testing products may be at an early stage in Latin America and Middle East & Africa, even if health care access improves; this should accelerate with greater awareness and affordability in these regions.
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
